NCT02831088 Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) Status UNKNOWN Phase PHASE2
NCT02829502 The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Status UNKNOWN Phase PHASE2
NCT02828540 Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke Status COMPLETED Phase PHASE2
NCT02823106 Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response Status WITHDRAWN Phase PHASE1
NCT02818868 Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial Status COMPLETED Phase N/A
NCT02814409 Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis Status COMPLETED Phase PHASE3
NCT02809651 Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner Status COMPLETED Phase NA
NCT02793687 Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy Status COMPLETED Phase PHASE3
NCT02787278 Safety and Efficacy of Two Doses of SP-8203 in Patients With Ischemic Stroke Requiring rtPA Status COMPLETED Phase PHASE2
NCT02785120 A Study to Evaluate the Efficacy and Safety of TF0023 Spray on Subjects With Ischemic Strokes Status SUSPENDED Phase PHASE2
NCT02777099 Impact of Remote Ischemic Postconditioning on Autonomic Function in Stroke Patients Status UNKNOWN Phase NA
NCT02767778 Low-frequency Pulsed Electromagnetic Fields (ELF-MF) as Treatment for Acute Ischemic Stroke Status TERMINATED Phase NA
NCT02720861 Prevalence of Genetic Polymporphism on RNF213 rs112735431 Gene in Non-cardioemboli Ischemic Cerebrovascular Disease Status UNKNOWN Phase N/A
NCT02678169 European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke Status COMPLETED Phase N/A